AbbVie Inc. $3 Billion 364-Day Term Loan Credit Facility
Davis Polk advised the lenders in connection with a $3 billion 364-day term loan credit facility for AbbVie Inc.
Headquartered in Chicago, Illinois, AbbVie is a global research…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Davis Polk Advises Charles River on Its Acquisition of MPI Research
Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $800 million acquisition of MPI Research Inc. The transaction, which is expected to close early in…
$3.1 Billion Financing for inVentiv’s Merger with INC Research
Davis Polk advised the administrative agent in connection with a $3.1 billion best-efforts financing comprised of a $1 billion senior secured term loan A facility, a $1.6 billion senior…
Davis Polk Advises PharMerica on Its Acquisition by KKR and Walgreens
Davis Polk is advising PharMerica Corporation on its approximately $1.4 billion acquisition by a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc. as a minority…
Davis Polk Advises Pernix Therapeutics Holdings, Inc. on Its Refinancing Transactions
Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with a series of refinancing transactions that are intended to improve liquidity, extend debt maturities and enable…
Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $6.25 Billion Refinancing
Davis Polk advised Valeant Pharmaceuticals International, Inc. in connection with a refinancing transaction pursuant to which Valeant issued new debt to refinance its shorter term…
Davis Polk Advises McKesson Corporation on $1 Billion Notes Offering by Change Healthcare
Davis Polk advised McKesson Corporation in connection with the offering of $1 billion aggregate principal amount of notes issued by Change Healthcare Holdings, LLC and Change Healthcare…
Magellan Pharmacy Services, Inc. $200 Million Term Loan
Davis Polk advised the administrative agent in connection with a $200 million delayed draw term loan facility for Magellan Pharmacy Services, Inc., a wholly owned subsidiary of…
Davis Polk Advises Aetna on the Sale of Medicare Advantage Assets to Molina Healthcare
Davis Polk is advising Aetna Inc. in connection with the sale by Aetna and Humana Inc. of certain of their respective Medicare Advantage assets to Molina Healthcare, Inc. for a total…
Magellan Pharmacy Services, Inc. $200 Million Term Loan Facility
Davis Polk advised the administrative agent in connection with a $200 million term loan facility (the “Credit Facility”) for Magellan Pharmacy Services, Inc., a wholly owned subsidiary of…